Johnson & Johnson JNJ
NYSE JNJ
$267.21 -1.91 (-0.71%)
As of: Sep 9, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Total Current Liabilities came in at $54.9 billion in Q2 2026, up 1.32% year-over-year from $54.2 billion in Q2 2025, and down 4.89% quarter-over-quarter from $57.7 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Total Current Liabilities (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Total Current Liabilities across 18 years of filings, most recently posting $54.9 billion for Q2 2026.

  • In Q2 2026, Total Current Liabilities rose 1.32% year-over-year to $54.9 billion; the TTM figure through Jun 2026 stood at $54.9 billion (up 1.32% YoY), while the FY2025 annual figure was $54.1 billion, up 7.56% from the prior year.
  • Total Current Liabilities came in at $54.9 billion for Q2 2026 at Johnson & Johnson, down from $57.7 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $60.4 billion in Q2 2023 to a low of $43.4 billion in Q2 2022.
  • Average Total Current Liabilities over 5 years is $51.2 billion, with a median of $51.8 billion recorded in 2024.
  • Year-over-year, Total Current Liabilities soared 39.14% in 2023 and declined 19.29% in 2024.
  • Over 5 years, Total Current Liabilities stood at $45.5 billion in 2022, then advanced by 1.62% to $46.3 billion in 2023, then climbed by 8.73% to $50.3 billion in 2024, then gained by 7.56% to $54.1 billion in 2025, then advanced by 1.42% to $54.9 billion in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $54.9 billion in Q2 2026, $57.7 billion in Q1 2026, and $54.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 54.90 Bn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 41.64 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn 31.75 Bn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 32.65 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn 37.11 Bn
7 Revolution Medicines 45.00 Bn 45.00 Bn - 354.06 Mn
8 Incyte 25.47 Bn 20.94 Bn 1.57 Bn 1.31 Bn
9 United Therapeutics 20.81 Bn 18.15 Bn 683.80 Mn 607.80 Mn
10 Jazz Pharmaceuticals 16.02 Bn 14.40 Bn 1.09 Bn 2.23 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 54.90 Bn
Mar 29, 2026 57.72 Bn
Dec 28, 2025 54.13 Bn
Sep 28, 2025 50.87 Bn
Jun 29, 2025 54.18 Bn
Mar 30, 2025 56.90 Bn
Dec 29, 2024 50.32 Bn
Sep 29, 2024 51.76 Bn
Jun 30, 2024 53.93 Bn
Mar 31, 2024 48.73 Bn
Dec 31, 2023 46.28 Bn
Oct 1, 2023 44.37 Bn
Jul 2, 2023 54.17 Bn
Apr 2, 2023 60.37 Bn
Jan 1, 2023 55.80 Bn
Oct 2, 2022 45.54 Bn
Jul 3, 2022 44.82 Bn
Apr 3, 2022 43.39 Bn
Jan 2, 2022 45.23 Bn
Oct 3, 2021 44.56 Bn